Gennex Laboratories

Gennex Laboratories EBITDA per Share

The EBITDA per Share of Gennex Laboratories (531739.BO) as of Oct 18, 2026 is 0.79 INR. In the previous year, EBITDA per Share was 1.11 INR — a change of -28.80% (lower).

EBITDA per Share

0.79INR

YoY

-28.80%

Last updated:

EBITDA per Share of Gennex Laboratories is 2026 0.79 INR. EBITDA per Share of Gennex Laboratories was 2025 1.11 INR. It decreases by -28.80% lower compared to the previous year.

The Gennex Laboratories EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
0.17 INR
Jan 1, 2020
0.13 INR
Jan 1, 2021
0.27 INR
Jan 1, 2022
0.22 INR
Jan 1, 2023
0.36 INR
Jan 1, 2024
0.90 INR
Jan 1, 2025
1.11 INR
Jan 1, 2026
0.79 INR
The Gennex Laboratories EBITDA per Share history
YEAREBITDA per ShareYoY
0.79INR-28.80%
1.11INR+23.07%
0.90INR+153.70%
0.36INR+60.77%
0.22INR-17.68%
0.27INR+101.20%
0.13INR-19.29%
0.17INR+83.48%
0.09INR-74.78%
0.36INR+7.91%
0.33INR+298.18%
0.08INR+8.86%
0.08INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gennex Laboratories Stock analysis

What does Gennex Laboratories do? Gennex Laboratories Ltd is a pharmaceutical manufacturer headquartered in Hyderabad, India, listed on the stock exchange in 1996. The company operates through its Pharmaceutical Products segment, specializing in the production of bulk drugs, intermediates, and biotech products. Its robust portfolio includes active pharmaceutical ingredients such as Guaifenesin, Methocarbamol, Phenazopyridine Hcl, Fluconazole, Mephenesin, Chlorphenesin, and Melitracen Hcl. These products serve various therapeutic areas, including expectorants, muscle relaxants, analgesics, anti-fungals, and antidepressants. Gennex Laboratories utilizes manufacturing facilities in India to supply both domestic and international markets, catering to the global demand for essential healthcare solutions within the health care sector. Gennex Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gennex Laboratories stock

EBITDA per Share of Gennex Laboratories is 0.79 INR in 2026.

EBITDA per Share of Gennex Laboratories changed from 1.11 INR to 0.79 INR, representing a -28.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Gennex Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Gennex Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Gennex Laboratories